Stocks and Investing Stocks and Investing
Thu, November 4, 2021
[ 12:00 AM ] - WOPRAI
Brent Thill Downgraded (ASAN) to Hold and Increased Target to $135 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Michael Cyprys Maintained (APO) at Buy with Increased Target to $90 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Gena Wang Maintained (BCRX) at Buy with Decreased Target to $17 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Brian Abrahams Maintained (BCRX) at Hold with Decreased Target to $14 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Michael King Maintained (AGIO) at Strong Buy with Increased Target to $95 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Michael Phillips Maintained (AIZ) at Buy with Increased Target to $191 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Mike Matson Maintained (ZBH) at Strong Buy with Decreased Target to $175 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Andrew Berens Maintained (ZYME) at Hold with Decreased Target to $28 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Jeffrey Stevenson Upgraded (BXC) to Strong Buy and Increased Target to $75 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Brian Johnson Maintained (BWA) at Hold with Increased Target to $48 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Joseph Spak Maintained (BWA) at Hold with Decreased Target to $47 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
James Lee Maintained (BKNG) at Strong Buy on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Brad Erickson Maintained (BKNG) at Hold on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Andrew Boone Maintained (BKNG) at Buy on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Brian Nowak Maintained (BKNG) at Hold on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Maurice Choy Maintained (BIP) at Buy with Increased Target to $43 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Kenneth Zener Maintained (BLD) at Buy with Increased Target to $300 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Trey Grooms Maintained (BLD) at Hold with Increased Target to $285 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Brian Vaccaro Maintained (CAKE) at Buy with Decreased Target to $53 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Lauren Silberman Maintained (CAKE) at Hold with Decreased Target to $52 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Brad Milsaps Upgraded (CADE) to Buy and Increased Target to $40 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
C. Gregory Peters Downgraded (ALL) to Buy and Decreased Target to $140 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Michael Pachter Downgraded (AMC) to Sell and Held Target at $66 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Whit Mayo Maintained (AMED) at Hold with Increased Target to $181 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Frank Morgan Maintained (AMED) at Buy with Decreased Target to $221 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Scott Fidel Maintained (AMED) at Hold with Increased Target to $185 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Jonathan Yong Maintained (AMED) at Buy with Increased Target to $205 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Danielle Antalffy Maintained (ATRC) at Buy with Increased Target to $110 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Mike Matson Maintained (ATRC) at Strong Buy with Increased Target to $92 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Joseph Schwartz Maintained (AUPH) at Buy with Increased Target to $35 on, Nov 4th, 2021

Joseph Schwartz Maintained (AUPH) at Buy with Increased Target to $35 on, Nov 4th, 2021


Published on 2024-10-27 18:30:08 - WOPRAI, Joseph Schwartz
  Print publication without navigation


Joseph Schwartz of SVB Leerink, Maintained "Aurinia Pharmaceuticals Inc." (AUPH) at Buy with Increased Target from $28 to $35 on, Nov 4th, 2021.

Joseph has made no other calls on AUPH in the last 4 months.



There is 1 other peer that has a rating on AUPH. Out of the 1 peers that are also analyzing AUPH, 0 agree with Joseph's Rating of Hold.



This is the rating of the analyst that currently disagrees with Joseph

  • Douglas Miehm of "RBC Capital" Maintained at Buy with Increased Target to $34 on, Tuesday, October 26th, 2021
Contributing Sources